Engineering the Recruitment of Phosphotyrosine Binding Domain-containing Adaptor Proteins Reveals Distinct Roles for RET Receptor-mediated Cell Survival*

The RET receptor tyrosine kinase is important for several different biological functions during development. The recruitment at the phosphorylated Tyr1062 site in RET of a number of different phosphotyrosine binding (PTB) domain-containing adaptor proteins, including Shc and Frs2, plays a dominant role for the multiple different biological functions of the RET receptor during development, including stimulation of cell survival. Here, we demonstrate that a competitive recruitment of Shc as opposed to Frs2 mediates the survival signaling arising from RET activation. Based on results from a peptide array, we have genetically engineered the PTB domain binding site of RET to rewire its recruitment of the PTB proteins Shc and Frs2. An engineered RET that has a competitive interaction with Shc at the expense of Frs2, but not a RET receptor that only recruits Frs2, activates cell survival signaling pathways and is protective from cell death in neuronal SK-N-MC cells. Thus, cell type-specific functions involve a competitive recruitment of different PTB adaptor molecules by RET that activate selective signaling pathways.

[1]  J. Milbrandt,et al.  Critical and distinct roles for key RET tyrosine docking sites in renal development. , 2006, Genes & development.

[2]  S. Eketjäll,et al.  Distinct Turnover of Alternatively Spliced Isoforms of the RET Kinase Receptor Mediated by Differential Recruitment of the Cbl Ubiquitin Ligase* , 2005, Journal of Biological Chemistry.

[3]  S. Bao,et al.  The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.

[4]  M. Ichihara,et al.  A Targeting Mutation of Tyrosine 1062 in Ret Causes a Marked Decrease of Enteric Neurons and Renal Hypoplasia , 2004, Molecular and Cellular Biology.

[5]  N. Hynes,et al.  Memo mediates ErbB2-driven cell motility , 2004, Nature Cell Biology.

[6]  R. Crowder,et al.  Tyrosine 981, a Novel Ret Autophosphorylation Site, Binds c-Src to Mediate Neuronal Survival* , 2004, Journal of Biological Chemistry.

[7]  E. Graaff,et al.  Enteric Nervous System Progenitors Are Coordinately Controlled by the G Protein-Coupled Receptor EDNRB and the Receptor Tyrosine Kinase RET , 2003, Neuron.

[8]  Masahide Takahashi,et al.  Role of Dok1 in Cell Signaling Mediated by RET Tyrosine Kinase* , 2002, The Journal of Biological Chemistry.

[9]  Masahide Takahashi,et al.  Novel Mechanism of Regulation of Rac Activity and Lamellipodia Formation by RET Tyrosine Kinase* , 2002, The Journal of Biological Chemistry.

[10]  M. Takahashi,et al.  The GDNF/RET signaling pathway and human diseases. , 2001, Cytokine & growth factor reviews.

[11]  V. D’Agati,et al.  Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. , 2001, Genes & development.

[12]  W. Birchmeier,et al.  Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation , 2001, The Journal of cell biology.

[13]  Masahide Takahashi,et al.  Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction , 2001, Oncogene.

[14]  D. Newgreen,et al.  GDNF is a chemoattractant for enteric neural cells. , 2001, Developmental biology.

[15]  G. D. Vita,et al.  The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret , 2001, Oncogene.

[16]  R. Scott,et al.  Signaling Complexes and Protein-Protein Interactions Involved in the Activation of the Ras and Phosphatidylinositol 3-Kinase Pathways by the c-Ret Receptor Tyrosine Kinase* , 2000, The Journal of Biological Chemistry.

[17]  S. Jhiang The RET proto-oncogene in human cancers , 2000, Oncogene.

[18]  M. Ichihara,et al.  Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor , 2000, Oncogene.

[19]  I. Lax,et al.  FRS2 Proteins Recruit Intracellular Signaling Pathways by Binding to Diverse Targets on Fibroblast Growth Factor and Nerve Growth Factor Receptors , 2000, Molecular and Cellular Biology.

[20]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[21]  A. Weiss,et al.  Induction of NF-κB by the Akt/PKB kinase , 1999, Current Biology.

[22]  T. Pawson,et al.  Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site , 1999, Oncogene.

[23]  S. Meakin,et al.  The Signaling Adapter FRS-2 Competes with Shc for Binding to the Nerve Growth Factor Receptor TrkA , 1999, The Journal of Biological Chemistry.

[24]  J. Milbrandt,et al.  Gene Targeting Reveals a Critical Role for Neurturin in the Development and Maintenance of Enteric, Sensory, and Parasympathetic Neurons , 1999, Neuron.

[25]  C. Eng RET proto-oncogene in the development of human cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Goldfarb,et al.  Novel Recognition Motif on Fibroblast Growth Factor Receptor Mediates Direct Association and Activation of SNT Adapter Proteins* , 1998, The Journal of Biological Chemistry.

[27]  J. Olefsky,et al.  Grb10 Interacts Differentially with the Insulin Receptor, Insulin-like Growth Factor I Receptor, and Epidermal Growth Factor Receptor via the Grb10 Src Homology 2 (SH2) Domain and a Second Novel Domain Located between the Pleckstrin Homology and SH2 Domains* , 1998, The Journal of Biological Chemistry.

[28]  T. Pawson,et al.  RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2 , 1997, Oncogene.

[29]  C. Worby,et al.  Glial Cell Line-derived Neurotrophic Factor Signals through the RET Receptor and Activates Mitogen-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[30]  N. Asai,et al.  A Mutation at Tyrosine 1062 in MEN2A-Ret and MEN2B-Ret Impairs Their Transforming Activity and Association with Shc Adaptor Proteins* , 1996, The Journal of Biological Chemistry.

[31]  Susan S. Taylor,et al.  Mitogenic Signaling by Ret/ptc2 Requires Association with Enigma via a LIM Domain* , 1996, The Journal of Biological Chemistry.

[32]  M. F. White,et al.  Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Apell,et al.  Affinity, Specificity, and Kinetics of the Interaction of the SHC Phosphotyrosine Binding Domain with Asparagine-X-X-Phosphotyrosine Motifs of Growth Factor Receptors (*) , 1996, The Journal of Biological Chemistry.

[34]  J. Bos,et al.  Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. , 1995, Oncogene.

[35]  A. Petros,et al.  Structure and ligand recognition of the phosphotyrosine binding domain of Shc , 1995, Nature.

[36]  M. White,et al.  PTB Domains of IRS-1 and Shc Have Distinct but Overlapping Binding Specificities (*) , 1995, The Journal of Biological Chemistry.

[37]  C. Turck,et al.  PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. , 1995, Science.

[38]  A. Craparo,et al.  Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain , 1995, Molecular and cellular biology.

[39]  T. Pawson,et al.  A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides , 1995, Current Biology.

[40]  al. et,et al.  Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B , 1995, Science.

[41]  B. Margolis,et al.  A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. , 1994, The Journal of biological chemistry.

[42]  Frank Costantini,et al.  Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret , 1994, Nature.

[43]  R. Frank Spot-synthesis: an easy technique for the positionally addressable, parallel chemical synthesis on a membrane support , 1992 .

[44]  H. Hiai,et al.  Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. , 1989, Oncogene.

[45]  T. Iwamoto,et al.  Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. , 1988, Oncogene.